ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS

Address

9924 Mesa Rim Road
SAN DIEGO, CA, 92121-2910

Information

DUNS: 021345447
# of Employees: 0

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: Y
Woman Owned: N

Award Charts




Award Listing

  1. Anti-RPS23RG1 Nanoantibody as Novel Therapeutic and Research Reagents for Alzheimer’s Disease.

    Amount: $225,000.00

    Abstract Alzheimerandapos s disease AD is the most common dementia in the elderly Currently there is no cure for the disease Pathologically AD is characterized by the presence of extracellular ...

    SBIRPhase I2016Department of Health and Human Services
  2. Adaptable and Automated Large-Scale Manufacturing of iPSC-Derived Cell Products

    Amount: $222,173.00

    Summary Statement and Abstract Stem cell technology is revolutionizing regenerative medicine and cell based therapies One of the promising applications of this technology is stem cell derived platele ...

    SBIRPhase I2016Department of Health and Human Services
  3. Generation and Characterization of Nanobodies Against beta-Amyloid

    Amount: $224,999.00

    DESCRIPTION provided by applicant Alzheimerandapos s disease AD is the most common dementia in the elderly and imposes a tremendous burden to patientsandapos families and the society both financ ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  4. Nano-Antibodies for Studying RNA Modifications

    Amount: $225,000.00

    DESCRIPTION (provided by applicant): The goal of the proposed Phase I research is to develop a set of commercial reagents for recognizing 2'-O-methyladenosine (Am), 2'-O-methylcytidine (Cm), ...

    SBIRPhase I2014Department of Health and Human Services
  5. RNA-Guided Gene Targeting in Human Cells

    Amount: $153,057.00

    Project Summary/Abstract The goal of the proposed Phase I research is to develop a set of commercial kits for footprint-free genome engineering. The core technologies that serve as the foundation of t ...

    SBIRPhase I2014Department of Health and Human Services
  6. Improving Pediatric Developmental Screening and Communication: A CME

    Amount: $199,939.00

    DESCRIPTION (provided by applicant): The goal of the proposed project is to develop a commercial kit that will allow drug addiction researchers with ongoing projects using cell-based models to be able ...

    SBIRPhase I2013Department of Health and Human Services
  7. TAS::75 0893::TAS SINGLE CHAIN ANTIBODIES AS RENEWABLE CAPTURE REAGENTS

    Amount: $200,000.00

    The main objective of this contract is to generate VHH antibodies against 10 addiction-relevant proteins. Protocols will be established for efficiently identifying single chain VHH antibodies from lla ...

    SBIRPhase I2011Department of Health and Human Services
  8. RNA Resource for Synthetic Lethal Screening of DNA Repair and

    Amount: $199,918.00

    The objectives of this proposal are to develop gene silencing reagents, and to test/validate their use in synthetic lethal screening of DNA damage signaling and repair pathways. Making such reagents ...

    SBIRPhase I2010Department of Health and Human Services
  9. SBIR PHASE I, TOPIC 239 YEAST SINGLE CHAIN ANTIBODIES AS CAPTURE REAGENTS

    Amount: $150,000.00

    N/A

    SBIRPhase I2007Department of Health and Human Services
  10. Cell Microarrays for High Throughput RNAi

    Amount: $99,510.00

    DESCRIPTION (provided by applicant): The goal of this proposal is to further develop and adapt our existing DNA-based RNAi technology to a cell microarray format for high throughput gene function stud ...

    SBIRPhase I2003Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government